iBio
IBIO
16 hedge funds and large institutions have $2.16M invested in iBio in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
14% more funds holding
Funds holding: 14 → 16 (+2)
11% more capital invested
Capital invested by funds: $1.95M → $2.16M (+$214K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$44.6K |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$6.38K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$6.38K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$25.5K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$22.3K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$15K |
| 4 |
Morgan Stanley
New York
|
-$3.19K |
IBIO Hedge Fund Activity: Q4 2015 in Review
16 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q4 2015, worth a combined $2.16M — up 11% from $1.95M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new IBIO positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $44.6K. The largest seller was BlackRock Institutional Trust, cutting an estimated $25.5K.
- 16 institutional investors held iBio (IBIO) as of Q4 2015, up from 14 in Q3 2015.
- Funds reported $2.16M of iBio stock for Q4 2015, up 11% quarter-over-quarter.
- 3 funds opened new iBio positions in Q4 2015 and 1 closed out, a net change of +2 holders.
- The largest iBio buyer in Q4 2015 was Citadel Advisors, an estimated $44.6K added.
- The largest iBio seller in Q4 2015 was BlackRock Institutional Trust, an estimated $25.5K sold.
Based on aggregated 13F filings for Q4 2015.